|
|
||||||||
Departments of Physiology and Biochemistry and Biophysics, University of North Carolina, Chapel Hill, North Carolina 27599-7260
| |
ABSTRACT |
|---|
|
|
|---|
The effects of mono- and divalent ions on
Ca2+-gated cardiac muscle
Ca2+-release channel (ryanodine
receptor) activity were examined in [3H]ryanodine-binding
measurements. Ca2+ bound with the
highest apparent affinity to Ca2+
activation sites in choline chloride medium, followed by KCl, CsCl,
NaCl, and LiCl media. The apparent
Ca2+ binding affinities of
Ca2+ inactivation sites were lower
in choline chloride and CsCl media than in LiCl, NaCl, and KCl media.
Sr2+ activated the ryanodine
receptor with a lower efficacy than
Ca2+. Competition studies
indicated that Li+,
K+,
Mg2+, and
Ba2+ compete with
Ca2+ for
Ca2+ activation sites. In 0.125 M
KCl medium, the Ca2+ dependence of
[3H]ryanodine binding
was modified by 5 mM Mg2+ and 5 mM
,
-methyleneadenosine 5'-triphosphate (a nonhydrolyzable ATP
analog). The addition of 5 mM glutathione was without appreciable effect. Substitution of Cl
by 2-(N-morpholino)ethanesulfonic acid ion caused an
increase in the apparent Ca2+
affinity of the Ca2+ inactivation
sites, whereas an increase in KCl concentration had the opposite
effect. These results suggest that cardiac muscle ryanodine receptor
activity may be regulated by 1)
competitive binding of mono- and divalent cations to
Ca2+ activation sites,
2) binding of monovalent cations to
Ca2+ inactivation sites, and
3) binding of anions to anion
regulatory sites.
sarcoplasmic reticulum
| |
INTRODUCTION |
|---|
|
|
|---|
IN MUSCLE, AN ACTION potential activates intracellular Ca2+-release channels to cause the release of Ca2+ from an intracellular Ca2+ compartment, the sarcoplasmic reticulum (SR), into the myofibrillar space (for review, see Refs. 5, 26). The SR Ca2+-release channels are also known as ryanodine receptors (RyRs) because they can bind the plant alkaloid ryanodine with high affinity and specificity (for review, see Refs. 3, 15). The cardiac muscle (RyR2) and skeletal muscle (RyR1) RyRs have been purified as 30S protein complexes composed of four large (relative molecular weight of ~560,000) (3, 15) and four small (FK-506-binding protein, relative molecular weight of ~12,000) (24) subunits. Physiological and biochemical evidence suggests that RyR1 and RyR2 are ligand-gated channels with Ca2+ as a major regulator. Activation by micromolar Ca2+ and inhibition by millimolar Ca2+ suggest at least two classes of Ca2+ binding sites, high-affinity activation sites and low-affinity inactivation sites. Various other endogenous and exogenous effectors have been identified, including Mg2+, ATP, calmodulin, caffeine, and ryanodine (3, 15, 30).
The neutral plant alkaloid ryanodine binds with nanomolar affinity and high specificity to RyRs and has been used as a sensitive probe in assessing the activity of RyRs (1, 16, 29). As a general rule, conditions that open the channel, such as the presence of micromolar Ca2+ or millimolar adenine nucleotide increase the affinity of [3H]ryanodine binding.
RyR activity is sensitive to ionic strength and composition, as
assessed in
[3H]ryanodine binding,
vesicle Ca2+ efflux, and
single-channel measurements. This phenomenon has been especially
observed for RyR1. Inorganic phosphate and anions often classified as
chaotropic ions (C
,
SCN
,
I
,
) stimulated RyR1 activity,
whereas replacement of Cl
by gluconate, propionate, and buffer anions such as
2-(N-morpholino)ethanesulfonic acid (MES) anion and
piperazine-N,N'-bis(2-ethanesulfonic
acid) (PIPES) anion was inhibitory (6, 7, 13, 18). An increase in KCl
or NaCl concentration increased RyR1 activity (1, 9, 16, 18, 19, 21).
In contrast, RyR2 activity has been reported to be only little affected
by ionic composition (6, 19).
It is well established that there exist major differences in the
regulation of the skeletal muscle and cardiac muscle receptor isoforms
by Ca2+,
Mg2+, ATP, and other endogenous
and exogenous effectors (3, 15). Here, we show that the two receptors
are regulated in a similar, but not identical, manner by mono- and
divalent ions. Our results indicate that cations regulate
Ca2+-gated RyR2 activity by at
least two different mechanisms: 1) competitive binding to high-affinity
Ca2+ activation sites and
2) binding to low-affinity
Ca2+ inactivation sites.
Cl
had an activating
effect.
| |
EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
Preparation of SR vesicles.
Cardiac SR vesicles enriched in
[3H]ryanodine binding
activity were prepared from canine hearts in the presence of protease inhibitors (100 nM aprotinin, 1 µM leupeptin, 1 µM pepstatin, 1 mM
benzamidine, and 0.2 mM phenylmethylsulfonyl fluoride) using a
discontinuous sucrose gradient of 20, 30, and 40% sucrose (17). Membranes at the 20%/30% sucrose interface were recovered,
quick-frozen in small aliquots, and stored at
135°C before
use. "Heavy" rabbit skeletal muscle SR vesicles were prepared in
the presence of the above protease inhibitors as described previously
(14). The maximum number of high-affinity
[3H]ryanodine binding
sites determined under optimal binding conditions (11) ranged from 2.5 to 8 pmol/mg protein for cardiac SR vesicles and from 11 to 23 pmol/mg
protein for skeletal muscle SR vesicles, depending on the preparations.
[3H]ryanodine binding measurements. Unless otherwise indicated, cardiac muscle and skeletal muscle SR vesicles were incubated for 40 and 96 h, respectively, at 12°C in 20 mM imidazole, pH 7.2, 0.2 mM Pefabloc SC, 20 µM leupeptin, 1 nM [3H]ryanodine, and the indicated salts and free Ca2+ concentrations. Nonspecific [3H]ryanodine binding was determined using a 1,000-fold excess of unlabeled ryanodine. Unbound [3H]ryanodine was separated from the protein-bound [3H]ryanodine by filtration of sample aliquots through Whatman GF/B filters presoaked with 2% polyethyleneimine, followed by washing with three 5-ml volumes of ice-cold 0.1 M KCl and 1 mM potassium PIPES (pH 7.0) medium. The radioactivity remaining with the filters was determined by liquid scintillation counting to obtain bound [3H]ryanodine.
Determination of free
[Ca2+]
and
[Sr2+].
Free Ca2+ concentrations of >1
µM were determined with a
Ca2+-selective electrode (World
Precision Instruments, Sarasota, FL). Free
Ca2+ concentrations of <1 µM
were obtained by including in the solutions the appropriate amounts of
Ca2+ and ethylene
glycol-bis(
-aminoethyl
ether)-N,N,N',N'-tetraacetic acid (EGTA) [or
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid and nitriloacetic acid] as determined using the stability constants and the mixed solution program published by Schoenmakers et
al. (22). Effects of Sr2+ were
determined in assay media containing contaminating levels of
Ca2+ (2-4 µM) and 1 mM
EGTA. Free Sr2+ concentrations
were calculated using the
EGTA-Sr2+
complexation constants published by Smith and Martell (23) and verified with a Ca2+-selective
electrode for Sr2+ concentrations
>100 µM.
Data analysis. The Ca2+ dependence of [3H]ryanodine binding was analyzed with the assumption that the RyR2 possesses cooperatively interacting high-affinity Ca2+ activation and low-affinity Ca2+ inactivation binding sites. A simple scheme used to describe the Ca2+ dependence of channel activity was
|
(Scheme 1) |
|
|
(1) |
|
(2a) |
|
(2b) |
Materials. [3H]ryanodine was purchased from DuPont NEN. Unlabeled ryanodine was obtained from Calbiochem, and leupeptin and Pefabloc SC (a protease inhibitor) were from Boehringer Mannheim. All other chemicals were of analytical grade.
| |
RESULTS |
|---|
|
|
|---|
Determination of the effects of ionic composition on the Ca2+ dependence of [3H]ryanodine binding. In the present study, a majority of the binding experiments was performed at a relatively low incubation temperature of 12°C to minimize loss of RyR activity during the [3H]ryanodine-binding reaction. The Ca2+ dependence of [3H]ryanodine binding to RyR2 was determined in 0.25 M KCl medium at four different time points to obtain the time required for equilibrium binding (Fig. 1). [3H]ryanodine binding had a Ca2+ threshold of ~1 µM, was optimal at 10-100 µM, and showed some inactivation in the 1-10 mM Ca2+ range. In agreement with previous studies (6, 12, 17, 27, 29), these results suggest that the cardiac receptor has both high-affinity Ca2+ activation sites and low-affinity Ca2+ inactivation sites. The [3H]ryanodine binding curves of Fig. 1 show that an incubation time of 40 h was sufficient to obtain close to equilibrium binding conditions.
|
|
|
7 M
Ca2+ and
[3H]ryanodine binding
showed little inhibition at high
Ca2+ concentrations. For RyR1,
substantial levels of binding were observed at
<10
8 M
Ca2+. These could be described
assuming that the choline ion is a weak, noncooperative
Ca2+ channel agonist of RyR1
(Eq. 2 of Ref. 18) but not RyR2. Table 1 lists the apparent KCaa and
na values for RyR2 in 0.25 M choline chloride medium.
Bell-shaped Ca2+
activation/inactivation curves were obtained for RyR2 in medium
containing the chloride salts of
Li+,
Na+,
K+, and
Cs+ at a concentration of 0.25 M
(Fig. 3). The binding levels were highest in KCl medium,
intermediate in CsCl and NaCl media, and lowest in LiCl medium.
Equation 1 provided a reasonable fit
(lines) to the
[3H]ryanodine-binding
data. Table 1 summarizes the Hill constants and coefficients in the
different media. The averaged
KCaa in
Li+,
Na+,
K+, and
Cs+ media were 32, 7.8, 1.7, and
3.6 µM, respectively. The highest apparent
Ca2+ binding affinities to the
Ca2+ inactivation sites were
obtained in LiCl and KCl media followed by NaCl and CsCl media. An
na of close to
two indicated that Ca2+ activated
[3H]ryanodine binding
by cooperative interactions involving at least two
Ca2+ binding sites. These results
suggest that monovalent cations affect RyR2 activity by interacting
with receptor Ca2+ activation and
inactivation sites.
|
by
MES
in the 0.25 M medium
decreased the maximal binding level about twofold.
Equation 1 provided a good fit (lines)
to the
[3H]ryanodine-binding
data determined in the five media shown in Fig. 4. Ionic strength and
anionic composition primarily affected the binding of
Ca2+ to the
Ca2+ inactivation sites (Table 1).
The KCai increased ~10-fold
as the KCl concentration was increased from 0.1 to 0.5 M KCl. A linear
correlation coefficient of 0.96 (n = 15) indicated that the increase in
KCai was highly significant. Replacement of Cl
by
MES
decreased
KCai 7.5-fold. Together, the
data of Figs. 2-4 suggest that both the actions of monovalent
cations and anions must be taken into account to understand the way in which Ca2+ activates and
inactivates RyR2.
|
Dependence of [3H]ryanodine binding on Sr2+ and Ba2+. Figure 5 compares the effects of Ca2+, Sr2+, and Ba2+ on [3H]ryanodine binding in 0.25 M KCl medium. Contaminating levels of Ca2+ (2-4 µM) were kept below 0.1 µM free Ca2+ by including 1 mM EGTA in the assay media. [3H]ryanodine binding had a higher threshold for Sr2+ than for Ca2+ (~10 µM vs. ~1 µM), was optimal at ~1 mM Sr2+, and showed some inactivation at 5 mM Sr2+. Ba2+ did not noticeably activate RyR2. The KCaa for Sr2+ (283 ± 21 µM, n = 3) and Ca2+ (1.7 ± 0.7 µM, Table 1) differed by more than a factor of 100. The Hill inactivation constant and Hill coefficients for Sr2+ did not significantly differ from those shown for Ca2+ in Table 1.
|
Effects of AMP and caffeine on Ca2+ dependence of [3H]ryanodine binding. The effects of two channel activators, AMP and caffeine (3, 15), on the Ca2+ dependence of [3H]ryanodine binding were determined in 0.25 M KCl medium. In these studies, AMP rather than ATP or a nonhydrolyzable ATP analog was used because AMP, in contrast to adenosine triphosphates, binds Ca2+ with negligible affinity. AMP (5 mM) did not significantly affect the Ca2+ binding affinity of the Ca2+ activation sites (Table 1). Ca2+ binding affinity to the Ca2+ inactivation sites of the receptor decreased approximately twofold. Caffeine (20 mM) increased the apparent Ca2+ affinity of the Ca2+ activation sites of the receptor by more than 15-fold. KCai increased approximately twofold (Table 1). Similar changes in the Hill constants and coefficients were obtained when the effects of 5 mM AMP and 20 mM caffeine were examined in 0.25 M LiCl, 0.25 M NaCl, or 0.25 M CsCl media (not shown).
Interaction of mono- and divalent cations with high-affinity Ca2+ activation sites of RyR2. We determined whether monovalent cations inhibit RyR2 activity by competing with Ca2+ for the Ca2+ activation sites, as observed for RyR1 (18). In these studies, we took advantage of the observation that, at low Ca2+ concentrations, the [3H]ryanodine-binding level was the highest in choline chloride medium (Fig. 2) by assessing the inhibitory effects of K+ in 0.5 M choline chloride medium containing varying low concentrations of free Ca2+ (Fig. 6). To interpret the [3H]ryanodine-binding data, three simple alternative types of inhibition were considered, namely, that K+ was a competitive, noncompetitive, or uncompetitive inhibitor. Choline ion was assumed to be without effect on RyR2 activity. As observed for RyR1 (18), the RyR2 binding data could not be fitted assuming non- or uncompetitive inhibition (not shown) but could be well fitted when it was assumed that K+ inhibited [3H]ryanodine binding by a competitive mechanism (Eqs. 2a and 2b, EXPERIMENTAL PROCEDURES) (Fig. 6). Table 2 summarizes the derived Hill Ca2+ activation and inactivation constants and coefficients for K+, as well as for Li+, Mg2+, and Ba2+. Similar Ca2+ activation constants were obtained for the four cations. Mg2+ was the most effective in inhibiting [3H]ryanodine binding (Ki = 0.007 mM). Ba2+ was ~100-fold less effective than Mg2+ in competing with Ca2+ for the Ca2+ activation sites. Of the two monovalent cations tested, Li+ was more effective than K+ in inhibiting [3H]ryanodine binding (Ki = 21 and 31 mM, respectively). The latter data are consistent with the observation that Ca2+ concentrations required to half-maximally activate [3H]ryanodine binding were higher for LiCl than for KCl medium (Fig. 3 and Table 1).
|
|
Effects of magnesium
,
-methyleneadenosine
5'-triphosphate and glutathione on
Ca2+ dependence
of [3H]ryanodine binding.
Attempts were made to determine the
Ca2+ dependence of
[3H]ryanodine binding
under more physiologically relevant conditions by performing
experiments at room temperature in 0.125 M KCl medium in the presence
of magnesium
,
-methyleneadenosine 5'-triphosphate (AMP-PCP)
and/or glutathione. In rat heart muscle, the myofibrillar concentrations of K+,
Na+, and
Cl
were estimated to be
74-128, 4-11, and 11-25 mM, respectively (25). The total
ATP and free Mg2+ concentrations
in intact hearts ranged from 5 to 10 mM (8, 10) and from 0.7 to 1.0 mM
(20), respectively. Figure 7 compares the
Ca2+ dependence of
[3H]ryanodine binding
at room temperature (~24°C) in 0.125 M KCl medium in the absence
and presence of 5 mM AMP-PCP and 5 mM
Mg2+ (~0.7 mM free
Mg2+ at ~1 µM
Ca2+). Addition of 5 mM
MgAMP-PCP shifted the Ca2+
activation curve to the right and rendered the channel less sensitive to inactivation at Ca2+
concentrations of up to 1 mM. Free
Ca2+ concentrations in excess of 1 mM were not tested because of difficulties of keeping
Ca2+ in solution in 5 mM AMP-PCP
medium. RyRs contain sulfhydryl groups that are important to their
function (30). These may be in a reduced state in vivo because cells
maintain a reducing environment by containing thiol-reducing compounds,
the most abundant being glutathione (4). Figure 7 shows that the
addition of a relatively high concentration of glutathione (5 mM) had a
minimal effect on the levels and
Ca2+ dependence of
[3H]ryanodine binding
in the 0.125 M KCl medium containing and lacking 5 mM MgAMP-PCP.
|
| |
DISCUSSION |
|---|
|
|
|---|
In the present study, the effects of mono- and divalent ions on the cardiac muscle RyR (Ca2+ release) channel were investigated by determining the Ca2+ dependence of [3H]ryanodine binding. These studies led to two new observations that may have important implications for the mechanism of SR Ca2+ release in cardiac muscle. First, the results of this study show that the affinity of Ca2+ binding to the Ca2+ activation sites and inactivation sites of RyR2 is dependent on ionic composition. Second, competition studies indicate that physiologically relevant mono- and divalent cations such as K+ and Mg2+ inhibit [3H]ryanodine binding by competitive binding to Ca2+ activation sites.
The Ca2+ dependence of Ca2+-release channel activity was examined by measuring [3H]ryanodine binding to SR vesicles. A low [3H]ryanodine concentration was used to limit binding to a single high-affinity receptor site. Under these conditions, [3H]ryanodine binding is a sensitive method in assessing RyR activity (3, 15). Although single-channel measurements provide more direct information on Ca2+-release channel activity than [3H]ryanodine binding measurements and channels gate on a much faster time scale than they bind [3H]ryanodine (µs to ms vs. min to h), an advantage of [3H]ryanodine binding is that it allows the study of a large number of ionic conditions.
One goal of this study was to find out how mono- and divalent ions affect the cardiac RyR. A second goal was to compare their effects on the cardiac and skeletal RyRs. Such a comparison is of interest because the two receptor isoforms are differently regulated by Ca2+ and other effectors. Because our studies with the skeletal muscle RyR were mostly performed with 0.25 M salt solutions (18), we chose 0.25 M solutions for most of our studies with the cardiac RyR as well. The binding parameters of RyR1 and RyR2 are summarized in Table 3 and are compared below.
|
The effects of monovalent cations on the
Ca2+ dependence of
[3H]ryanodine binding
were determined by using the chloride salts of
Li+,
Na+,
K+, and
Cs+. The same order of apparent
Ca2+ binding affinities was
obtained for the two receptor isoforms, however, with RyR1 displaying
higher apparent Ca2+ binding
affinities than RyR2 (Table 3). Values of
na of 1.9 and
greater indicate that Ca2+
activated RyR2 by a cooperative interaction involving at least two
Ca2+ activation sites. In choline
chloride medium, the Ca2+
dependence of
[3H]ryanodine binding
differed in that, at free Ca2+
<10
8 M, significant
levels of
[3H]ryanodine binding
were observed for RyR1 but not RyR2, which suggests an apparent agonist
action of choline ion for RyR1 (18) but not RyR2. Another difference
was that at micromolar Ca2+
concentrations, the
[3H]ryanodine binding
level of RyR2 was higher in KCl than choline chloride medium, whereas
the opposite was observed for RyR1 (Fig. 2). This result suggests that
monovalent cations may influence the activity of RyR2 in additional
ways, not indicated by the scheme in EXPERIMENTAL
PROCEDURES.
Differences were observed in apparent binding affinities of Ca2+ to the inactivation sites of the cardiac and skeletal muscle RyR and the order of the affinities in the various monovalent cation media (Table 3). For RyR2, the Ca2+ affinities were similar in LiCl, NaCl, and KCl media. In CsCl and choline chloride media, decreased affinities were observed. Values for ni of Ca2+ binding to the cardiac Ca2+ inactivation sites ranged from 0.7 to 1.4, suggesting that Ca2+ bound with no or low cooperativity to the Ca2+ inactivation sites. Our results are consistent with previous SR vesicle Ca2+ flux (2, 17), single-channel (12, 27), and [3H]ryanodine binding (2, 6, 27) measurements; these studies also showed an activation and inactivation of RyR2 by Ca2+ in K+ or Cs+ media, but they are at variance with a study that failed to show an inhibition of single-channel activities by 10 mM Ca2+ (2).
Major differences were observed in the action of divalent cations. Ca2+ and Sr2+ activated RyR2, whereas Mg2+ and Ba2+ inhibited [3H]ryanodine binding by competing with Ca2+ for the Ca2+ activation sites. Divalent cations similarly affected [3H]ryanodine binding to RyR1 (D. A. Pasek and G. Meissner, unpublished observations) (Table 3). The results of the present study also indicate competitive binding of monovalent cations to the Ca2+ activation sites of RyR2 to affect the receptor's Ca2+ sensitivity. The inhibition constants of K+ and Mg2+ were 42 and 0.013 mM for RyR1 and 31 and 0.007 mM for RyR2, respectively (Table 3). The intracellular K+ and free Mg2+ concentrations in cardiomyocytes have been estimated to be 74-128 mM (25) and 0.4-0.8 mM (20), respectively. Therefore, in cardiomyocytes a small fraction of the Ca2+-release channel's Ca2+ activation sites may be occupied by K+ instead of Mg2+ at rest. Occupation of some sites by K+ may be of physiological significance because Ca2+ may bind faster to channel sites occupied by K+ than sites occupied by more tightly bound Mg2+.
The activity of RyR1 is greatly affected by the anionic composition of
assay medium (6, 7, 13, 18). In 0.25 M
K+-MES, RyR1 bound only close to
baseline levels of
[3H]ryanodine (18).
Substitution of Cl
by
MES
also reduced the
[3H]ryanodine binding
levels of RyR2 but to a lesser extent. Substitution of
Cl
by MES
appeared to primarily affect
[3H]ryanodine binding
to RyR2 by causing a decrease in
KCai. Increase
of KCl concentration from 0.1 to 0.5 M had an opposite effect by
increasing
KCai of RyR2.
It therefore appears that RyR2 is also sensitive to regulation by
anions.
The Ca2+ dependence of [3H]ryanodine binding was analyzed under conditions that were thought to approximate those in the myocardium. These included the use of a 0.125 M KCl medium containing 5 mM MgAMP-PCP and/or 5 mM glutathione (Fig. 7). The addition of 5 mM MgAMP-PCP modified the Ca2+ dependence of RyR2 by rendering the channel less sensitive to activation at Ca2+ concentrations of <10 µM and less sensitive to Ca2+ inactivation at Ca2+ concentrations of >100 µM. Glutathione has recently been shown to reduce the affinity and maximal binding values but not Ca2+ dependence of [3H]ryanodine binding to skeletal muscle RyR (28). At variance with this result, the addition of 5 mM glutathione had a minimal effect on both the level and Ca2+ dependence of [3H]ryanodine binding to cardiac RyR.
In conclusion, the results of this study show that monovalent ions affect in a similar, but not identical, manner the in vitro regulation of the cardiac and skeletal muscle Ca2+-release channels by Ca2+. In the absence of other activating ligands, Ca2+ activates the cardiac channel to a greater extent than the skeletal channel (17). Two possible explanations for this difference that we considered in our experiments were an increased Ca2+ affinity of the Ca2+ activation sites and decreased Ca2+ affinity of the Ca2+ inactivation sites. A consequence of a widened "Ca2+ window" is that higher levels of receptor activation can be achieved. Our results indicate that Ca2+ bind to the Ca2+ inactivation sites of the cardiac receptors with a lower apparent affinity than those in the skeletal muscle receptor, whereas Ca2+ bind with a somewhat higher apparent affinity to the Ca2+ activation sites of the skeletal than cardiac muscle RyR. Accordingly, differences in Ca2+ binding affinity to the Ca2+ inactivation sites may be primarily responsible for the different activity levels of the two receptors.
| |
ACKNOWLEDGEMENTS |
|---|
Support by National Institutes of Health Grants HL-27430 and AR-18687 is gratefully acknowledged.
| |
FOOTNOTES |
|---|
Address for reprint requests: G. Meissner, Dept. of Biochemistry and Biophysics, Univ. of North Carolina, Chapel Hill, NC 27599-7260.
Received 14 May 1997; accepted in final form 12 September 1997.
| |
REFERENCES |
|---|
|
|
|---|
1.
Chu, A.,
M. Diaz-Munoz,
M. J. Hawkes,
K. Brush,
and
S. L. Hamilton.
Ryanodine as a probe for the functional state of the skeletal muscle sarcoplasmic reticulum calcium release channel.
Mol. Pharmacol.
37:
735-741,
1990[Abstract].
2.
Chu, A.,
M. Fill,
E. Stefani,
and
M. L. Entman.
Cytoplasmic Ca2+ does not inhibit the cardiac muscle sarcoplasmic reticulum ryanodine receptor Ca2+ channel, although Ca2+-induced Ca2+ inactivation of Ca2+ release is observed in native vesicles.
J. Membr. Biol.
135:
49-59,
1993[Medline].
3.
Coronado, R.,
J. Morrissette,
M. Sukhareva,
and
D. M. Vaughan.
Structure and function of ryanodine receptors.
Am. J. Physiol.
266 (Cell Physiol. 35):
C1485-C1504,
1994
4.
Deneke, S. M.,
and
B. L. Fanburg.
Regulation of cellular glutathione.
Am. J. Physiol.
257 (Lung Cell. Mol. Physiol. 1):
L163-L173,
1989
5.
Fabiato, A.
Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum.
Am. J. Physiol.
245 (Cell Physiol. 14):
C1-C14,
1983
6.
Fruen, B. R.,
P. K. Kane,
J. R. Mickelson,
and
C. F. Louis.
Chloride-dependent sarcoplasmic reticulum Ca2+ release correlates with increased Ca2+ activation of ryanodine receptors.
Biophys. J.
71:
2522-2530,
1996[Medline].
7.
Hasselbach, W.,
and
A. Migala.
Modulation by monovalent anions of calcium and caffeine induced calcium release from heavy sarcoplasmic reticulum vesicles.
Z. Naturforsch. [C]
47:
440-448,
1992.
8.
Hohl, C. M.,
A. A. Garleb,
and
R. A. Altschuld.
Effects of simulated ischemia and reperfusion on the sarcoplasmic reticulum of digitonin-lysed cardiomyocytes.
Circ. Res.
70:
716-723,
1992
9.
Kasai, M.,
N. Yamaguchi,
and
T. Kawasaki.
Effect of KCl concentration on gating properties of calcium release channels in sarcoplasmic reticulum vesicles.
J. Biochem. (Tokyo)
117:
251-256,
1995
10.
Koretsune, Y.,
M. C. Corretti,
H. Kusuoka,
and
E. Marban.
Mechanism of early ischemic contractile failure: inexcitability, metabolic accumulation, or vascular collapse?
Circ. Res.
68:
255-262,
1991
11.
Lai, F. A.,
M. Misra,
L. Xu,
H. A. Smith,
and
G. Meissner.
The ryanodine receptor-Ca2+ release channel complex of skeletal muscle sarcoplasmic reticulum. Evidence for a cooperatively coupled, negatively charged homotetramer.
J. Biol. Chem.
264:
16776-16785,
1989
12.
Laver, D. R.,
L. D. Roden,
G. P. Ahern,
K. R. Eager,
P. R. Junankar,
and
A. F. Dulhunty.
Cytoplasmic Ca2+ inhibits the ryanodine receptor from cardiac muscle.
J. Membr. Biol.
147:
7-22,
1995[Medline].
13.
Ma, J.,
K. Anderson,
R. Shirokov,
R. Levis,
A. Gonzalez,
M. Karhanek,
M. M. Hosey,
G. Meissner,
and
E. Rios.
Effects of perchlorate on the molecules of excitation-contraction coupling of skeletal and cardiac muscle.
J. Gen. Physiol.
102:
423-448,
1993
14.
Meissner, G.
Adenine nucleotide stimulation of Ca2+-induced Ca2+ release in sarcoplasmic reticulum.
J. Biol. Chem.
259:
2365-2374,
1984
15.
Meissner, G.
Ryanodine receptor/Ca2+ release channels and their regulation by endogenous effectors.
Annu. Rev. Physiol.
56:
485-508,
1994[Medline].
16.
Meissner, G.,
and
A. El-Hashem.
Ryanodine as a functional probe of the skeletal muscle sarcoplasmic reticulum Ca2+ release channel.
Mol. Cell. Biochem.
114:
119-123,
1992[Medline].
17.
Meissner, G.,
and
J. S. Henderson.
Rapid calcium release from cardiac sarcoplasmic reticulum vesicles is dependent on Ca2+ and is modulated by Mg2+, adenine nucleotide, and calmodulin.
J. Biol. Chem.
262:
3065-3073,
1987
18.
Meissner, G.,
E. Rios,
A. Tripathy,
and
D. A. Pasek.
Regulation of skeletal muscle Ca2+ release channel (ryanodine receptor) by Ca2+ and monovalent cations and anions.
J. Biol. Chem.
272:
1628-1638,
1997
19.
Michalak, M.,
P. Dupraz,
and
V. Shoshan-Barmatz.
Ryanodine binding to sarcoplasmic reticulum membrane; comparison between cardiac and skeletal muscle.
Biochim. Biophys. Acta
939:
587-594,
1988[Medline].
20.
Murphy, E.,
C. Steenbergen,
L. A. Levy,
B. Raju,
and
R. E. London.
Cytosolic free magnesium levels in ischemic rat heart.
J. Biol. Chem.
264:
5622-5627,
1989
21.
Ogawa, Y.,
and
H. Harafuji.
Osmolarity-dependent characteristics of [3H]ryanodine binding to sarcoplasmic reticulum.
J. Biochem. (Tokyo)
107:
894-898,
1990
22.
Schoenmakers, J. M.,
G. J. Visser,
G. Flik,
and
A. P. R. Theuvene.
CHELATOR: an improved method for computing metal ion concentrations in physiological solutions.
Biotechniques
12:
870-879,
1992[Medline].
23.
Smith, R. M.,
and
A. E. Martell.
Critical Stability Constants. New York: Plenum, 1974, vol. 1.
24.
Timerman, A. P.,
H. Onoue,
H. B. Xin,
S. Barg,
J. Copello,
G. Wiederrecht,
and
S. Fleischer.
Selective binding of FKBP12.6 by the cardiac ryanodine receptor.
J. Biol. Chem.
271:
20385-20391,
1996
25.
Von Zglinicki, T.,
and
M. Bimmler.
The intracellular distribution of ions and water in rat liver and heart muscle.
J. Microsc.
146:
77-85,
1987[Medline].
26.
Wier, W. G.
Cytoplasmic Ca2+ in mammalian ventricle: dynamic control by cellular processes.
Annu. Rev. Physiol.
52:
467-485,
1990[Medline].
27.
Xu, L.,
G. Mann,
and
G. Meissner.
Regulation of cardiac Ca2+ release channel (ryanodine receptor) by Ca2+, H+, Mg2+, and adenine nucleotides under normal and simulated ischemic conditions.
Circ. Res.
79:
1100-1109,
1996
28.
Zable, A. C.,
T. C. Favero,
and
J. J. Abramson.
Glutathione modulates ryanodine receptor from skeletal muscle sarcoplasmic reticulum. Evidence for redox regulation of the Ca2+ release mechanism.
J. Biol. Chem.
272:
7069-7077,
1997
29.
Zimanyi, I.,
and
I. N. Pessah.
Comparison of [3H]ryanodine receptors and Ca2+ release from rat cardiac and rabbit skeletal muscle sarcoplasmic reticulum.
J. Pharmacol. Exp. Ther.
256:
938-946,
1991
30.
Zucchi, R.,
and
S. Ronca-Testoni.
The sarcoplasmic reticulum Ca2+ channel/ryanodine receptor: modulation by endogenous effectors, drugs and disease states.
Pharmacol. Rev.
49:
1-51,
1997
This article has been cited by other articles:
![]() |
A. Chugun, O. Sato, H. Takeshima, and Y. Ogawa Mg2+ activates the ryanodine receptor type 2 (RyR2) at intermediate Ca2+ concentrations Am J Physiol Cell Physiol, January 1, 2007; 292(1): C535 - C544. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Kargacin, Z. Ali, S.-J. Zhang, N. S. Pollock, and M. E. Kargacin Iodide and bromide inhibit Ca2+ uptake by cardiac sarcoplasmic reticulum Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1624 - H1634. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sagawa, M. Nishio, K. Sagawa, J. E. Kelly, A. J. Lokuta, J. Tsai, E. Kan, and J. A. Wasserstrom Activation of purified cardiac ryanodine receptors by dihydropyridine agonists Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1201 - H1207. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Halet, P. Viard, J.-L. Morel, J. Mironneau, and C. Mironneau Effects of hindlimb suspension on cytosolic Ca2+ and [3H]ryanodine binding in cardiac myocytes Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1131 - H1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zhao, P. Li, S. R. W. Chen, C. F. Louis, and B. R. Fruen Dantrolene Inhibition of Ryanodine Receptor Ca2+ Release Channels. MOLECULAR MECHANISM AND ISOFORM SELECTIVITY J. Biol. Chem., April 20, 2001; 276(17): 13810 - 13816. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Beutner, V. K. Sharma, D. R. Giovannucci, D. I. Yule, and S.-S. Sheu Identification of a Ryanodine Receptor in Rat Heart Mitochondria J. Biol. Chem., June 8, 2001; 276(24): 21482 - 21488. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |